Neuropace Pb Ratio vs Roe Analysis

NPCE Stock  USD 10.66  0.96  9.90%   
Neuropace financial indicator trend analysis is infinitely more than just investigating Neuropace recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neuropace is a good investment. Please check the relationship between Neuropace Pb Ratio and its Roe accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuropace. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Neuropace Stock refer to our How to Trade Neuropace Stock guide.

Pb Ratio vs Roe

Pb Ratio vs Roe Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neuropace Pb Ratio account and Roe. At this time, the significance of the direction appears to have pay attention.
The correlation between Neuropace's Pb Ratio and Roe is -0.91. Overlapping area represents the amount of variation of Pb Ratio that can explain the historical movement of Roe in the same time period over historical financial statements of Neuropace, assuming nothing else is changed. The correlation between historical values of Neuropace's Pb Ratio and Roe is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pb Ratio of Neuropace are associated (or correlated) with its Roe. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Roe has no effect on the direction of Pb Ratio i.e., Neuropace's Pb Ratio and Roe go up and down completely randomly.

Correlation Coefficient

-0.91
Relationship DirectionNegative 
Relationship StrengthSignificant

Pb Ratio

Roe

Most indicators from Neuropace's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neuropace current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuropace. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Neuropace Stock refer to our How to Trade Neuropace Stock guide.The current year's Enterprise Value is expected to grow to about 433.9 M, whereas Selling General Administrative is forecasted to decline to about 44.6 M.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization296K3.0M1.6M1.6M
Interest Income448K1.6M3.1M3.2M

Neuropace fundamental ratios Correlations

0.020.88-0.930.96-0.980.960.7-0.93-0.47-0.850.850.690.70.620.570.990.70.680.98-0.10.610.950.98-0.840.95
0.020.080.080.15-0.20.190.680.020.76-0.430.52-0.340.670.27-0.64-0.120.360.45-0.05-0.380.77-0.080.08-0.260.18
0.880.08-0.870.81-0.890.830.66-0.89-0.53-0.850.810.830.630.740.410.850.920.780.780.050.670.760.91-0.660.8
-0.930.08-0.87-0.80.88-0.8-0.651.00.640.8-0.77-0.86-0.65-0.81-0.42-0.92-0.75-0.63-0.85-0.27-0.48-0.78-0.970.58-0.78
0.960.150.81-0.8-0.971.00.74-0.81-0.27-0.860.860.50.70.460.570.940.620.730.97-0.360.690.970.9-0.951.0
-0.98-0.2-0.890.88-0.97-0.97-0.790.890.330.89-0.93-0.62-0.8-0.65-0.46-0.94-0.76-0.73-0.940.19-0.75-0.91-0.960.87-0.96
0.960.190.83-0.81.0-0.970.76-0.82-0.26-0.890.870.520.710.490.530.930.660.780.96-0.360.720.950.9-0.951.0
0.70.680.66-0.650.74-0.790.76-0.70.12-0.930.930.330.940.72-0.140.60.740.840.61-0.170.910.550.76-0.670.74
-0.930.02-0.891.0-0.810.89-0.82-0.70.610.85-0.79-0.86-0.68-0.83-0.38-0.91-0.79-0.7-0.85-0.24-0.53-0.78-0.980.6-0.79
-0.470.76-0.530.64-0.270.33-0.260.120.610.18-0.04-0.870.14-0.38-0.61-0.56-0.32-0.12-0.43-0.580.26-0.41-0.50.03-0.24
-0.85-0.43-0.850.8-0.860.89-0.89-0.930.850.18-0.92-0.58-0.83-0.74-0.14-0.78-0.83-0.94-0.760.12-0.84-0.72-0.880.74-0.86
0.850.520.81-0.770.86-0.930.870.93-0.79-0.04-0.920.450.960.730.120.760.820.770.77-0.20.920.720.88-0.790.86
0.69-0.340.83-0.860.5-0.620.520.33-0.86-0.87-0.580.450.30.750.40.710.730.510.580.540.20.530.78-0.240.48
0.70.670.63-0.650.7-0.80.710.94-0.680.14-0.830.960.30.75-0.130.580.740.660.6-0.130.90.530.76-0.640.7
0.620.270.74-0.810.46-0.650.490.72-0.83-0.38-0.740.730.750.75-0.150.540.870.60.450.510.590.340.78-0.220.44
0.57-0.640.41-0.420.57-0.460.53-0.14-0.38-0.61-0.140.120.4-0.13-0.150.680.030.060.68-0.25-0.120.750.42-0.550.55
0.99-0.120.85-0.920.94-0.940.930.6-0.91-0.56-0.780.760.710.580.540.680.610.620.99-0.090.490.970.95-0.820.93
0.70.360.92-0.750.62-0.760.660.74-0.79-0.32-0.830.820.730.740.870.030.610.770.540.170.780.490.8-0.460.61
0.680.450.78-0.630.73-0.730.780.84-0.7-0.12-0.940.770.510.660.60.060.620.770.6-0.170.780.590.72-0.650.75
0.98-0.050.78-0.850.97-0.940.960.61-0.85-0.43-0.760.770.580.60.450.680.990.540.6-0.240.520.990.91-0.890.96
-0.1-0.380.05-0.27-0.360.19-0.36-0.17-0.24-0.580.12-0.20.54-0.130.51-0.25-0.090.17-0.17-0.24-0.37-0.340.070.63-0.4
0.610.770.67-0.480.69-0.750.720.91-0.530.26-0.840.920.20.90.59-0.120.490.780.780.52-0.370.50.64-0.70.7
0.95-0.080.76-0.780.97-0.910.950.55-0.78-0.41-0.720.720.530.530.340.750.970.490.590.99-0.340.50.85-0.920.96
0.980.080.91-0.970.9-0.960.90.76-0.98-0.5-0.880.880.780.760.780.420.950.80.720.910.070.640.85-0.720.88
-0.84-0.26-0.660.58-0.950.87-0.95-0.670.60.030.74-0.79-0.24-0.64-0.22-0.55-0.82-0.46-0.65-0.890.63-0.7-0.92-0.72-0.96
0.950.180.8-0.781.0-0.961.00.74-0.79-0.24-0.860.860.480.70.440.550.930.610.750.96-0.40.70.960.88-0.96
Click cells to compare fundamentals

Neuropace Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Neuropace is a strong investment it is important to analyze Neuropace's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuropace's future performance. For an informed investment choice regarding Neuropace Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuropace. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Neuropace Stock refer to our How to Trade Neuropace Stock guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuropace. If investors know Neuropace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuropace listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.98)
Revenue Per Share
2.697
Quarterly Revenue Growth
0.282
Return On Assets
(0.15)
Return On Equity
(2.15)
The market value of Neuropace is measured differently than its book value, which is the value of Neuropace that is recorded on the company's balance sheet. Investors also form their own opinion of Neuropace's value that differs from its market value or its book value, called intrinsic value, which is Neuropace's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuropace's market value can be influenced by many factors that don't directly affect Neuropace's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuropace's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuropace is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuropace's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.